5 Best Small-Cap Growth Stocks to Invest In
In this piece, we will take a look at the five best small-cap growth stocks to invest in.
Sarepta Therapeutics Inc. (SRPT)
Market is closed
News
- First
- << Previous
- 21 - 30
- Next >>
Growth Stock Portfolio: 15 Companies with At Least 30% Annual Growth Rates
In this article, we will take a look at the 15 stocks with at least 30% annual growth rates to consider for a growth stock portfolio.
5 Best Mid-Cap Growth Stocks To Buy Now
California-based cybersec company SentinelOne Inc (NYSE:S) shares have gained about 56% over the past six months. Earlier this month SentinelOne Inc (NYSE:S) posted strong third quarter results.
15 Best Fast Growth Stocks to Buy Now
In this article, we will take a look at the 15 best fast growth stocks to buy now.
13 High Growth Healthcare Stocks to Buy
In this article, we will take a look at 13 high growth healthcare stocks to buy.
5 Stocks Insiders and Billionaires Are Crazy About
This article presents an overview of the 5 Stocks Insiders and Billionaires Are Crazy About. For a detailed overview of such stocks, read our article, 11 Stocks Insiders and Billionaires Are Crazy...
10 Beaten Down Stocks Billionaires Are Crazy About
In this article, we will take a look at the 10 beaten down stocks billionaires are crazy about.
5 Best Upside Stocks To Buy Now
In this piece, we will take a look at the five best upside stocks to buy right now.
13 Stocks Insiders are Buying Now
With the end of 2023 now in sight, many can say with confidence that the much-dreaded recession everyone was talking about will not realize this year.
Here’s What Bronte Capital Calls “Sarepta Risk” in the Context of Sarepta Therapeutics (SRPT)
Bronte Capital, an investment management company, released its “Amalthea Fund” third-quarter 2023 investor letter. A copy of the same can be downloaded here.
- First
- << Previous
- 21 - 30
- Next >>
Billionaire Hedge Funds
